Summary
The sensitivity of the mammographic screening test in the biennial screening program of Nijmegen is assessed by analyzing the occurrence of interval cancers, i.e. cancers surfacing clinically in the interval between a negative screening examination and the subsequent scheduled examination. The difference between the observed number of interval cancers and the expected number of clinically manifest cancers in the absence of screening for the interval period reflects the number of cancers detected by screening. The expected number should be limited by the number of those cancers that were not detectable at the time of the screening examination because their size was under the threshold of mammographic detectability (5 mm). In contrast to other sensitivity studies we took these ‘fast growing’ cancers into consideration, the numbers of which are estimated in each of the six-month periods of the two-year interval using age-specific tumor volume growth rates for three age groups: < 50, 50–69, and ≥ 70 years. In patients under age 50, the sensitivity was 64% for cancers which would become clinically manifest within one year after screening. This sensitivity was lower than those obtained from the 50–69 and ≥ 70 age groups, being 85% and 80%, respectively. For cancers that would become clinically manifest 12–18 months after screening, sensitivity decreases to 22% in the under age 50 group, and to 56% and 65% in the two above age 50 groups, respectively. We conclude that even when adjusted for growth rate, the mammographic screening test has a poor performance in the under age 50 group.
References
Hurley SF, Kaldor JM: The benefits and risks of mammographic screening for breast cancer. Epidemiol Rev 14: 101–130, 1992
Fletcher SW, Black W, Harris R, Rimer BK, Shapiro S: Report of the International Workshop on Screening for Breast Cancer. J Natl Cancer Inst 85: 1644–1656, 1993
Peer PGM, van Dijck JAAM, Hendriks JHCL, Holland R, Verbeek ALM: Age-dependent growth rate of primary breast cancer. Cancer 71: 3547–3551, 1993
Day NE, Walter SD: Simplified models of screening for chronic disease: estimation procedures from mass screening programmes. Biometrics 40: 1–14, 1984
Frisell J, Eklund G, Hellström L, Somell A: Analysis of interval breast carcinomas in a randomized screening trial in Stockholm. Breast Cancer Res Treat 9: 219–225, 1987
Baines CJ, McFarlane DV, Miller AB: The role of the reference radiologist. Estimates of inter-observer agreement and potential delay in cancer detection in the National Breast Screening Study. Investigative Radiology 25: 971–976, 1990
Van Dijck JAAM, Verbeek ALM, Hendriks JHCL, Holland R: The current detectability of breast cancer in a mammographic screening program. A review of the previous mammograms of interval and screen-detected cancers. Cancer 72: 1933–1938, 1993
Tabár L, Fagerberg G, Day NE, Holmberg L: What is the optimum interval between mammographic screening examinations? — An analysis based on the latest results of the Swedish two-county breast cancer screening trial. Br J Cancer 55: 547–551, 1987
Paci E, Ciatto S, Buiatti E, Cecchini S, Palli D, Rosselli del Turco M: Early indicators of efficacy of breast cancer screening programmes. Results of the Florence district programme. Int J Cancer 46: 198–202, 1990
Frisell J, Eklund G, Hellström L, Lidbrink E, Rutqvist LE, Somell A: Randomized study of mammography screening — preliminary report on mortality in the Stockholm trial. Breast Cancer Res Treat 18: 49–56, 1991
Brekelmans CTM, Collette HJA, Collette C, Fracheboud J, de Waard F: Breast cancer after a negative screen: follow-up of women participating in the DOM screening programme. Eur J Cancer 28A: 893–895, 1992
Moss SM, Coleman DA, Ellman R, Chamberlain J, Forrest APM, Kirkpatrick AE, Thomas BA, Price JL: Interval cancers and sensitivity in the screening centres of the UK trial of early detection of breast cancer. Eur J Cancer 29A: 255–258, 1993
Day NE: Estimating the sensitivity of a screening test. J Epidemiol Community Health 39: 364–366, 1985
Peeters PHM, Verbeek ALM, Hendriks JHCL, van Bon MJH: Screening for breast cancer in Nijmegen. Report of 6 screening rounds, 1975–1986. Int J Cancer 43: 226–230, 1989
Day NE, Williams DRR, Khaw KT: Breast cancer screening programmes: the development of a monitoring and evaluation system. Br J Cancer 59: 954–958, 1989
Alexander FE: Estimation of sojourn time distributions and false negative rates in screening programmes which use two modalities. Statistics in Medicine 8: 743–755, 1989
Brookmeyer R, Day NE: Two-stage models for the analysis of cancer screening data. Biometrics 43: 657–669, 1987
Day NE, Walter SD, Tabár L, Fagerberg CJG, Collette HJA: The sensitivity and lead time of breast cancer screening: a comparison of the results of different studies. In: Day N, Miller A (eds) Screening for Breast Cancer. Hans Huber Publishers, Toronto, 1988, pp 105–109
Van Oortmarssen GJ, Habbema JDF, Lubbe TN, van der Maas PJ: A model-based analysis of the HIP project for breast cancer screening. Int J Cancer 46: 207–213, 1990
Paci E, Duffi SW: Modelling the analysis of breast cancer screening programmes: sensitivity, lead time and predictive value in the Florence district programme (1975–1986). Int J Epidemiol 20: 852–858, 1991
Tabár L, Fagerberg G, Duffy SW, Day NE, Gad A, Gröntoft O: Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin N Am 30: 187–210, 1992
Van Oortmarssen GJ, Habbema JDF, van der Maas PJ, de Koning HJ, Collette HJA, Verbeek ALM, Geerts AT, Lubbe KTN: A model for breast cancer screening. Cancer 66: 1601–1612, 1990
Peeters PHM, Verbeek ALM, Straatman H, Holland R, Hendriks JHCL, Mravunac M, Rothengatter C, van Dijk-Milatz A, Werre JM: Evaluation of overdiagnosis of breast cancer screening with mammography. Results of the Nijmegen programme. Int J Epidemiol 18: 295–299, 1989
Grove JS, Goodman MJ, Gilbert FI, Low G: Estimating the sensitivity of breast cancer screening — Experience with the Honolulu BCDDP data. Breast Cancer Res Treat 18: S97-S101, 1991
Moskowitz M: Breast cancer: Age-specific growth rates and screening strategies. Radiology 161: 37–41, 1986
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Peer, P.G., Verbeek, A.L., Straatman, H. et al. Age-specific sensitivities of mammographic screening for breast cancer. Breast Cancer Res Tr 38, 153–160 (1996). https://doi.org/10.1007/BF01806669
Issue Date:
DOI: https://doi.org/10.1007/BF01806669